Tech Company Financing Transactions
Theron Pharmaceuticals Funding Round
Theron Pharmaceuticals, operating out of Sunnyvale, received $409.1 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
8/6/2015
Transaction Type
Venture Equity
Amount
$409,099
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
365 San Aleso Ave.
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Overview
Founded in 2008, Theron Pharmaceuticals is a privately held biotechnology company developing a best-in-class, long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jurg Pfister
Co-Founder
Venkat Venkatraman
Co-Founder
Xiaoming Zhang
Browse more venture capital transactions:
Prev: 8/6/2015: Sensics venture capital transaction
Next: 8/6/2015: Patent Navigation venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs